2-carboxy-2-(4-methoxybenzylthio)indane | 150280-09-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 2-carboxy-2-(4-methoxybenzylthio)indane
• 英文别名: 2-carboxy-2-(4-methoxybenzylthio)indan；2-[(4-methoxyphenyl)methylsulfanyl]-1,3-dihydroindene-2-carboxylic acid
• CAS: 150280-09-4
• 化学式: C₁₈H₁₈O₃S
• 分子量: 314.405
• InChiKey: VIXPGRNEGAJOBZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  71.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (2S,5S)-5-amino-4-oxo-1,2,4,5,6,7-hexahydro-azaepino[3,2,1-hi]indole-2-carboxylic acid methyl ester 、 2-carboxy-2-(4-methoxybenzylthio)indane 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成
  参考文献：
  名称：

  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by tricyclic benzazepinone thiols

  摘要：

  Various thioacyl analogs of CGS 28106, a tricyclic dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, have been synthesized and their inhibitory potencies evaluated in vitro. The structure-activity relationship supports the proposed hypothesis that, despite its conformational constraints, CGS 28106 can inhibit the two distinct metalloproteases by adopting different binding modes. Tn addition, the structural features of CGS 28106 confer remarkable oral activity to this dual inhibitor, as measured by its ability to block the angiotensin-I presser response and to potentiate plasma levels of atrial natriuretic peptide. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00529-x
• 作为产物：
  描述：

  1,2-bis(4-methoxybenzyl)disulfide 在 sodium hydroxide 、 lithium diisopropyl amide 作用下， 以 甲醇 为溶剂， 生成 2-carboxy-2-(4-methoxybenzylthio)indane
  参考文献：
  名称：

  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by tricyclic benzazepinone thiols

  摘要：

  Various thioacyl analogs of CGS 28106, a tricyclic dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, have been synthesized and their inhibitory potencies evaluated in vitro. The structure-activity relationship supports the proposed hypothesis that, despite its conformational constraints, CGS 28106 can inhibit the two distinct metalloproteases by adopting different binding modes. Tn addition, the structural features of CGS 28106 confer remarkable oral activity to this dual inhibitor, as measured by its ability to block the angiotensin-I presser response and to potentiate plasma levels of atrial natriuretic peptide. Copyright (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/s0960-894x(96)00529-x

文献信息

• 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful
  申请人：Merrell Dow Pharmaceuticals, Inc.

  公开号：US05420271A1

  公开（公告）日：1995-05-30

  The present invention relates to novel 2-substitited indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.

  这项发明涉及一种新颖的2-取代的茚-2-巯基乙酰胺三环衍生物，可用作脑啡肽酶的抑制剂。
• 2-substituted indane-2-mercaptoacetylamide derivatives useful as
  申请人：Merrell Dow Pharmaceuticals Inc.

  公开号：US05428158A1

  公开（公告）日：1995-06-27

  The present invention relates to novel 2-substituted indane-2-mercaptoacetylamide derivatives which are useful as inhibitors of enkephalinase and ACE.

  本发明涉及新型的2-取代的茚-2-巯基乙酰胺衍生物，可用作脑啡肽酶和ACE的抑制剂。
• Indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors
  申请人：Merrell Pharmaceuticals Inc.

  公开号：US05604221A1

  公开（公告）日：1997-02-18

  The present invention relates to certain novel indane-2-mercaptoacetylamide disulfide derivatives of the formula ##STR1## useful as inhibitors of enkephalinase.

  这项发明涉及某些新颖的公式为##STR1##的茚-2-巯基乙酰胺二硫化物衍生物，可用作脑啡肽酶抑制剂。
• Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
  申请人：MERRELL PHARMACEUTICALS INC.

  公开号：EP0534363A2

  公开（公告）日：1993-03-31

  The present invention relates to novel 2-substituted indane-2-mercaptoacetylaminde derivatives which are useful as inhibitors of enkephalinase and ACE.

  本发明涉及新型 2-取代茚满-2-巯基乙酰胺衍生物，可用作脑啡肽酶和 ACE 的抑制剂。
• NOVEL 2-SUBSTITUTED INDANE-2-MERCAPTOACETYLAMIDE TRICYCLIC DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE
  申请人：MERRELL PHARMACEUTICALS INC.

  公开号：EP0656001B1

  公开（公告）日：1999-09-15